Found: 54
Select item for more details and to access through your institution.
Cytotoxic T-cell response and in vivo protection against tumor cells harboring activated ras proto-oncogenes.
- Published in:
- 1993
- By:
- Publication type:
- journal article
Multi-center phase II trial of bortezomib and rituximab maintenance combination therapy in patients with mantle cell lymphoma after consolidative autologous stem cell transplantation.
- Published in:
- Journal of Hematology & Oncology, 2018, v. 11, n. 1, p. N.PAG, doi. 10.1186/s13045-018-0631-3
- By:
- Publication type:
- Article
Genetic fusion of chemokines to a self tumor antigen induces protective, T-cell dependent antitumor immunity.
- Published in:
- Nature Biotechnology, 1999, v. 17, n. 3, p. 253, doi. 10.1038/6995
- By:
- Publication type:
- Article
Translational development of active immunotherapy for hematologic malignancies.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Designer cancer vaccines are still in fashion.
- Published in:
- Nature Medicine, 2000, v. 6, n. 9, p. 966, doi. 10.1038/79649
- By:
- Publication type:
- Article
Complete molecular remissions induced by patient-specific vaccination plus granulocyte?monocyte colony-stimulating factor against lymphoma.
- Published in:
- Nature Medicine, 1999, v. 5, n. 10, p. 1171, doi. 10.1038/13928
- By:
- Publication type:
- Article
Phase I study of an active immunotherapy for asymptomatic phase Lymphoplasmacytic lymphoma with DNA vaccines encoding antigen-chemokine fusion: study protocol.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Autologous lymphoma vaccines induce human T cell responses against multiple, unique epitopes.
- Published in:
- Journal of Clinical Investigation, 2004, v. 113, n. 10, p. 1498, doi. 10.1172/JCI200420312
- By:
- Publication type:
- Article
Autologous lymphoma vaccines induce human T cell responses against multiple, unique epitopes.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Defensins act as potent adjuvants that promote cellular and humoral immune responses in mice to a lymphoma idiotype and carrier antigens.
- Published in:
- International Immunology, 2000, v. 12, n. 5, p. 691, doi. 10.1093/intimm/12.5.691
- By:
- Publication type:
- Article
Generation of a new therapeutic peptide that depletes myeloid-derived suppressor cells in tumor-bearing mice.
- Published in:
- Nature Medicine, 2014, v. 20, n. 6, p. 676, doi. 10.1038/nm.3560
- By:
- Publication type:
- Article
Vaccine-induced tumor-specific immunity despite severe B-cell depletion in mantle cell lymphoma.
- Published in:
- 2005
- By:
- Publication type:
- Letter
Long‐term overall‐ and progression‐free survival after pentostatin, cyclophosphamide and rituximab therapy for indolent non‐Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2019, v. 185, n. 4, p. 670, doi. 10.1111/bjh.15814
- By:
- Publication type:
- Article
Rituximab plus hyper-CVAD alternating with MTX/Ara-C in patients with newly diagnosed mantle cell lymphoma: 15-year follow-up of a phase II study from the MD Anderson Cancer Center.
- Published in:
- British Journal of Haematology, 2016, v. 172, n. 1, p. 80, doi. 10.1111/bjh.13796
- By:
- Publication type:
- Article
CCL3 and CCL4 are biomarkers for B cell receptor pathway activation and prognostic serum markers in diffuse large B cell lymphoma.
- Published in:
- British Journal of Haematology, 2015, v. 171, n. 5, p. 726, doi. 10.1111/bjh.13659
- By:
- Publication type:
- Article
Phase II study of an AKT inhibitor MK2206 in patients with relapsed or refractory lymphoma.
- Published in:
- British Journal of Haematology, 2015, v. 171, n. 4, p. 463, doi. 10.1111/bjh.13603
- By:
- Publication type:
- Article
Phase II study of HCVIDD/ MA in patients with newly diagnosed peripheral T-cell lymphoma.
- Published in:
- British Journal of Haematology, 2015, v. 171, n. 4, p. 509, doi. 10.1111/bjh.13628
- By:
- Publication type:
- Article
Pentostatin, cyclophosphamide and rituximab for previously untreated advanced stage, low-grade B-cell lymphomas.
- Published in:
- British Journal of Haematology, 2015, v. 169, n. 6, p. 814, doi. 10.1111/bjh.13367
- By:
- Publication type:
- Article
Detection of classical Hodgkin lymphoma specific sequence in peripheral blood using a next-generation sequencing approach.
- Published in:
- British Journal of Haematology, 2015, v. 169, n. 5, p. 689, doi. 10.1111/bjh.13349
- By:
- Publication type:
- Article
<sup>90</sup>Y-ibritumomab tiuxetan radiotherapy as first-line therapy for early stage low-grade B-cell lymphomas, including bulky disease.
- Published in:
- British Journal of Haematology, 2014, v. 167, n. 2, p. 207, doi. 10.1111/bjh.13021
- By:
- Publication type:
- Article
<sup>90</sup>Y-ibritumomab tiuxetan radiotherapy as first-line therapy for early stage low-grade B-cell lymphomas, including bulky disease.
- Published in:
- British Journal of Haematology, 2014, v. 166, n. 1, p. 1, doi. 10.1111/bjh.13021
- By:
- Publication type:
- Article
Prospective phase II study of rituximab with alternating cycles of hyper- CVAD and high-dose methotrexate with cytarabine for young patients with high-risk diffuse large B-cell lymphoma.
- Published in:
- British Journal of Haematology, 2013, v. 163, n. 5, p. 611, doi. 10.1111/bjh.12585
- By:
- Publication type:
- Article
Phase I study of vorinostat in combination with standard CHOP in patients with newly diagnosed peripheral T-cell lymphoma.
- Published in:
- British Journal of Haematology, 2013, v. 162, n. 1, p. 138, doi. 10.1111/bjh.12326
- By:
- Publication type:
- Article
Bone Marrow Stromal Cells Derived MCP-1 Reverses the Inhibitory Effects of Multiple Myeloma Cells on Osteoclastogenesis by Upregulating the RANK Expression.
- Published in:
- PLoS ONE, 2013, v. 8, n. 12, p. 1, doi. 10.1371/journal.pone.0082453
- By:
- Publication type:
- Article
Dose-Related Safety and Immunogenicity of Baculovirus-Expressed Trivalent Influenza Vaccine: A Double-Blind, Controlled Trial in Adult Patients with Non-Hodgkin B Cell Lymphoma.
- Published in:
- Journal of Infectious Diseases, 2006, v. 194, n. 10, p. 1394, doi. 10.1086/508493
- By:
- Publication type:
- Article
Organic solvent extraction of proteins and peptides from serum as an effective sample preparation for detection and identification of biomarkers by mass spectrometry.
- Published in:
- Proteomics, 2004, v. 4, n. 4, p. 1195, doi. 10.1002/pmic.200300677
- By:
- Publication type:
- Article
Antitumor efficacy of BAFF-R targeting CAR T cells manufactured under clinic-ready conditions.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 10, p. 2139, doi. 10.1007/s00262-020-02614-8
- By:
- Publication type:
- Article
Targeting myeloid-derived suppressor cells for cancer immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 8, p. 1181, doi. 10.1007/s00262-018-2175-3
- By:
- Publication type:
- Article
MACOP-B +/- radiation therapy for diffuse large cell lymphoma. Analysis of the Stanford results according to prognostic indices.
- Published in:
- 1993
- By:
- Publication type:
- journal article
Clinical significance of morphologic subdivision in diffuse large cell lymphoma.
- Published in:
- 1991
- By:
- Publication type:
- journal article
B-cell malignancies as a model for cancer vaccines: from prototype protein to next generation genetic chemokine fusions.
- Published in:
- Immunological Reviews, 1999, v. 170, n. 1, p. 115, doi. 10.1111/j.1600-065X.1999.tb01333.x
- By:
- Publication type:
- Article
Zoledronic Acid for Prevention of Bone Loss in Patients Receiving Primary Therapy for Lymphomas: A Prospective, Randomized Controlled Phase III Trial.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2013, v. 13, n. 2, p. 99, doi. 10.1016/j.clml.2012.11.002
- By:
- Publication type:
- Article
The Absolute Monocyte and Lymphocyte Prognostic Index for Patients With Diffuse Large B-Cell Lymphoma Who Receive R-CHOP.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2013, v. 13, n. 1, p. 15, doi. 10.1016/j.clml.2012.09.009
- By:
- Publication type:
- Article
Experience with heat shock protein‐peptide complex 96 vaccine therapy in patients with indolent non‐Hodgkin lymphomaPresented in part at the 39th annual meeting of the American Society of Clinical Oncology, May 31, 2003‐June 3, 2003, Chicago, Illinois.
- Published in:
- Cancer (0008543X), 2007, v. 109, n. 1, p. 77, doi. 10.1002/cncr.22389
- By:
- Publication type:
- Article
The changing investment in translational science by academic medical centers: HOPE in the Valley of Death.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Phase I Trial of Brentuximab Vedotin Plus Cyclosporine in Relapsed/Refractory Hodgkin Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 10, p. 724, doi. 10.1016/j.clml.2024.05.017
- By:
- Publication type:
- Article
Efficacy and Safety of CT-P10 Versus Rituximab in Untreated Low-Tumor-Burden Follicular Lymphoma: Final Results of a Randomized Phase III Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 2, p. 89, doi. 10.1016/j.clml.2021.08.005
- By:
- Publication type:
- Article
Pegylated liposomal doxorubicin replacing conventional doxorubicin in standard R-CHOP chemotherapy for elderly patients with diffuse large B-cell lymphoma: an open label, single arm, phase II trial.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Selective targeting of Toll-like receptors and OX40 inhibit regulatory T-cell function in follicular lymphoma.
- Published in:
- International Journal of Cancer, 2014, v. 135, n. 12, p. 2834, doi. 10.1002/ijc.28937
- By:
- Publication type:
- Article
A modified human ELISPOT assay to detect specific responses to primary tumor cell targets.
- Published in:
- Journal of Translational Medicine, 2004, v. 2, p. 9, doi. 10.1186/1479-5876-2-9
- By:
- Publication type:
- Article
Efficient Modulation of T-cell Response by Dual-mode, Single-carrier Delivery of Cytokine-targeted siRNA and DNA Vaccine to Antigen-presenting Cells.
- Published in:
- Molecular Therapy, 2008, v. 16, n. 12, p. 2011, doi. 10.1038/mt.2008.206
- By:
- Publication type:
- Article
Absence of Grail promotes CD8<sup>+</sup> T cell anti-tumour activity.
- Published in:
- Nature Communications, 2017, v. 8, n. 1, p. 1, doi. 10.1038/s41467-017-00252-w
- By:
- Publication type:
- Article
Phase 2 trial of bortezomib in combination with rituximab plus hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with bortezomib, rituximab, methotrexate, and cytarabine for untreated mantle cell lymphoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Phase 2 Trial of Rituximab Plus Hyper-CVAD Alternating With Rituximab Plus Methotrexate- Cytarabine for Relapsed or Refractory Aggressive Mantle Cell Lymphoma.
- Published in:
- Cancer (0008543X), 2008, v. 113, n. 10, p. 2734, doi. 10.1002/cncr.23880
- By:
- Publication type:
- Article
Verapamil synergistically enhances cytotoxicity of bortezomib in mantle cell lymphoma via induction of reactive oxygen species production.
- Published in:
- British Journal of Haematology, 2012, v. 159, n. 2, p. 243, doi. 10.1111/bjh.12003
- By:
- Publication type:
- Article
Phase I study of bortezomib plus ICE (BICE) for the treatment of relapsed/refractory Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2011, v. 154, n. 2, p. 284, doi. 10.1111/j.1365-2141.2011.08618.x
- By:
- Publication type:
- Article
Targeting cell surface β.
- Published in:
- British Journal of Haematology, 2011, v. 154, n. 1, p. 111, doi. 10.1111/j.1365-2141.2011.08714.x
- By:
- Publication type:
- Article
Phase I trial of bortezomib in combination with rituximab-HyperCVAD alternating with rituximab, methotrexate and cytarabine for untreated aggressive mantle cell lymphoma.
- Published in:
- British Journal of Haematology, 2010, v. 151, n. 1, p. 47, doi. 10.1111/j.1365-2141.2010.08315.x
- By:
- Publication type:
- Article
Corrigendum to "Prime-Boost Vaccination Using Chemokine-Fused gp120 DNA and HIV Envelope Peptides Activates Both Immediate and Long-Term Memory Cellular Responses in Rhesus Macaques".
- Published in:
- BioMed Research International, 2020, p. 1, doi. 10.1155/2020/5471638
- By:
- Publication type:
- Article
Personalized neoantigen vaccines as early intervention in untreated patients with lymphoplasmacytic lymphoma: a non-randomized phase 1 trial.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-50880-2
- By:
- Publication type:
- Article